Crosslink between p53 and metastasis: focus on epithelial–mesenchymal transition, cancer stem cell, angiogenesis, autophagy, and anoikis,Molecular Biology Reports

当前位置： X-MOL 学术 › Mol. Biol. Rep. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Crosslink between p53 and metastasis: focus on epithelial–mesenchymal transition, cancer stem cell, angiogenesis, autophagy, and anoikis
Molecular Biology Reports ( IF 2.6 ) Pub Date : 2021-09-14 , DOI: 10.1007/s11033-021-06706-1
Ghader Babaei _{1,

2} , Azadeh Aliarab ₃ , Mehdi Asghari Vostakolaei ₄ , Masumeh Hotelchi ₃ , Roghaiyeh Neisari ₅ , Shiva Gholizadeh-Ghaleh Aziz ₁ , Masumeh Rajabi Bazl ₃

Affiliation

Introduction

P53, as a tumor suppressor gene, is believed to be one of the most mutated genes in cancer cells. The mutant forms of this protein often play a tumorigenic role in cancer cells. Recent evidence shows that p53 plays a critical role in the migration, metastasis, and invasion of cancer cells. The present article aims to investigate the molecular mechanism that induces metastasis in cancer cells generated by the mutant P53, and to highlight the compounds targeting mutant-p53 together with their clinical applications.

Methods

A detailed literature search was conducted to find information about the role of the mutant-p53 in the processes involved in metastasis in various databases.

Results

A growing body of evidence suggests that Mutant-p53 enhances tumor metastasis affecting the Epithelial-mesenchymal transition (EMT) process, cancer stem cells, angiogenesis, autophagy, anoikis, and any other mechanisms regarding metastasis.

Conclusions

Taken together, targeting mutant-p53 by altering the processes involved in metastasis could be a potential therapeutic strategy in the treatment of metastatic cancer.